Depressive Disorders
Trauma
David Dansky, MD, FACEP
president
Monterey Integrated Therapies
The use of Ketamine as a potential treatment for depression and PTSD has gained significant attention in recent years. The session will provide an overview of the mechanism of action and pharmacology of Ketamine, the evidence supporting its use in these disorders, and provide practical tips for the use of Ketamine in clinical practice, including dosing, administration, monitoring, and patient selection.
The aim of this session is to equip attendees with the knowledge and skills to effectively use Ketamine as a treatment option for depression and PTSD in their clinical practice.